10 Year Financial Data of MetLife Inc (MET)

43.28 (1y: +40%)

Market Cap	46.61 B	P/E(ttm)	20.10
Enterprise Value	68.63 B	P/B	0.73

MET- NYSE (USA)
MetLife Inc

Currently 1/5

Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$43.28

2 Severe Warning Signs 5 Medium Warning Signs 1 Good Sign

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	2.2	1.2	-2.1
EBITDA Growth (%)	0	0	-58.8
Free Cash Flow Growth (%)	1.7	11.6	11.5
Book Value Growth (%)	7.7	17.2	5.9

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	47.46	51.63	59.30	62.78	69.49	68.46	50.16	59.26	65.78	63.29	64.50	14.96	17.19	15.50	15.79	16.02
EBITDA per Share	4.12	5.58	6.29	5.99	7.92	7.34	-4.66	5.11	10.02	1.89	3.41	-0.38	3.12	-0.95	0.11	1.13
Free Cashflow per Share	9.76	10.67	10.60	8.56	1.56	14.37	3.94	8.99	9.63	15.94	13.11	5.41	5.93	2.99	1.71	2.48
Earnings per Share ($)	2.94	3.65	6.16	7.99	5.48	4.14	-2.89	3.00	6.29	1.12	2.16	-0.16	2.12	-0.92	0.09	0.87
Dividends Per Share	0.23	0.46	0.52	0.59	0.74	0.74	0.74	0.74	0.74	0.74	0.93	--	--	--	0.74	0.19
Book Value per Share	28.05	30.21	38.54	43.85	46.12	31.87	40.47	54.66	55.98	59.85	58.38	55.12	58.32	60.14	58.73	58.38
Month End Stock Price	33.84	40.51	49.00	59.01	61.62	34.86	35.35	44.44	31.18	32.94	38.02	37.35	30.85	34.46	32.94	38.02
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	10.50	12.10	16.20	18.60	12.30	13.50	-6.80	5.70	11.70	2.10	6.00	-0.80	14.80	-6.00	0.80	6.00
Return on Assets %	0.70	0.80	1.00	1.20	0.80	0.60	-0.40	0.40	0.90	0.20	0.40	--	1.20	-0.40	--	0.40
Debt to Equity	0.44	0.39	0.46	0.45	0.42	0.68	0.52	0.75	0.46	0.35	0.34	0.46	0.36	0.42	0.35	0.34

Operating Margin %	7.30	9.70	9.80	8.70	11.40	10.00	-10.60	7.50	14.30	2.10	7.10	-2.60	18.10	-6.10	-2.80	7.10
Net Margin %	6.20	7.10	10.50	13.00	8.10	6.30	-5.50	5.30	9.90	1.90	5.60	-0.90	12.50	-5.80	0.70	5.60

Debt to Revenue	0.26	0.23	0.30	0.31	0.28	0.32	0.42	0.69	0.39	0.33	1.25	1.68	1.21	1.64	1.29	1.25
Interest Exp. to Revenue %	-1.34	-1.05	-1.47	-1.86	-2.11	-1.09	-2.13	-1.81	-1.52	-2.10	-1.83	-2.38	-1.97	-2.09	-2.01	-1.83

Asset Turnover	0.11	0.11	0.09	0.09	0.10	0.10	0.08	0.07	0.09	0.08	0.02	0.02	0.02	0.02	0.02	0.02
Buyback Ratio	-45.40	-1.80	-1.50	-1.30	--	-102	45.40	-128	-42.30	-73.40	--	--	--	--	-73.40	--
Dividend Payout Ratio	0.08	0.13	0.08	0.07	0.13	0.17	--	0.24	0.11	0.60	0.21	--	--	--	6.40	0.21
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Total Premiums Earned	23,169	25,216	28,688	26,412	27,895	25,914	26,460	27,394	36,361	37,975	37,997	9,129	9,161	9,096	10,589	9,151
Net Investment Income	11,636	12,418	14,910	17,192	19,006	16,296	14,838	17,615	19,606	21,984	21,861	6,200	4,719	5,517	5,548	6,077
Fees and Other Income	984	1,380	1,178	4,792	6,106	8,779	-240	7,708	14,295	8,191	10,059	587	4,518	1,890	1,196	2,455
Revenue	35,789	39,014	44,776	48,396	53,007	50,989	41,058	52,717	70,262	68,150	69,917	15,916	18,398	16,503	17,333	17,683

Selling, General, &Admin. Expense	--	--	--	--	--	7,410	7,716	9,021	14,151	14,662	14,116	3,903	3,591	3,581	3,587	3,357
Policyholder Benefits & Claims	44,731	48,322	54,937	58,108	61,397	27,437	28,336	29,545	35,457	37,987	38,278	9,104	8,911	8,943	11,029	9,395
Policy Acquisition Expense	2,474	2,876	3,266	3,811	4,114	--	--	--	--	--	--	--	--	--	--	--
Earnings Before DDA	3,108	4,220	4,751	4,615	6,039	5,465	-3,813	4,543	10,705	2,038	3,694	-409	3,338	-1,010	119	1,247

Depreciation, Depletion and Amortization	478	441	352	394	--	375	520	585	679	596	596	--	--	--	596	--

Operating Income	2,630	3,779	4,399	4,221	6,039	5,090	-4,333	3,958	10,026	1,442	3,098	-409	3,338	-1,010	-477	1,247
Net Income	2,217	2,758	4,714	6,293	4,317	3,209	-2,246	2,790	6,981	1,324	2,454	-144	2,295	-954	127	986

Preferred dividends	--	--	63.00	134	137	125	122	122	122	122	122	30.00	31.00	30.00	31.00	30.00
Earnings per Share ($)	2.94	3.65	6.16	7.99	5.48	4.14	-2.89	3.00	6.29	1.12	2.16	-0.16	2.12	-0.92	0.09	0.87
Total Shares Outstanding	754	756	755	771	763	745	818	890	1,068	1,077	1,104	1,064	1,070	1,065	1,097	1,104
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Fixed Maturity Investment	167,752	176,763	230,050	--	--	188,251	227,642	327,284	350,271	374,266	374,294	354,451	366,339	378,005	374,266	374,294
Equity Investments	1,598	2,188	3,338	5,131	6,050	3,197	3,084	3,606	3,023	2,891	3,188	3,043	2,882	2,803	2,891	3,188
Short-term investments	1,826	2,663	3,306	2,709	2,648	14,824	10,758	27,976	35,578	16,906	30,241	30,827	36,854	30,673	16,906	30,241
Net Loan	8,749	8,899	9,981	10,228	57,449	61,166	60,970	74,290	83,985	68,890	67,395	80,484	70,853	71,119	68,890	67,395
Cash and cash equivalents	3,733	4,051	4,018	7,107	10,368	24,207	10,112	13,046	10,461	15,738	9,983	18,667	16,035	16,950	15,738	9,983
Accounts Receivable	7,047	6,696	12,186	14,490	14,607	16,973	17,068	19,830	22,481	21,634	23,052	23,759	23,974	22,939	21,634	23,052
Deferred Policy Acquisition Costs	12,943	14,336	19,641	20,851	21,521	20,144	19,256	27,307	27,971	24,761	24,645	25,105	24,505	24,604	24,761	24,645
Intangible Assets	--	--	4,797	4,897	4,910	5,008	5,047	11,781	11,935	9,953	9,696	11,903	11,823	10,024	9,953	9,696
Total Assets	326,841	356,808	481,645	527,715	558,562	501,678	539,314	730,906	799,625	836,781	841,685	819,604	825,188	846,285	836,781	841,685

Unpaid Loss & Loss Reserve	176,392	190,713	259,847	270,171	279,787	--	--	--	--	--	--	--	--	--	--	--
Future Policy Benefits	94,148	100,159	123,204	127,489	132,262	130,555	135,879	173,373	184,252	192,351	190,054	184,141	188,509	191,068	192,351	190,054
Policyholder Funds	82,244	90,554	136,643	142,682	148,314	158,590	147,119	212,726	220,619	225,821	224,044	220,813	225,909	226,882	225,821	224,044
Current Portion of Long-Term Debt	3,642	1,445	1,414	1,449	667	2,659	912	306	686	100.00	100.00	101	101	100.00	100.00	100.00
Other liabilities	-58,138	-57,791	-81,572	-63,656	-53,532	141,314	180,915	230,333	265,169	293,158	302,365	286,731	272,822	284,232	293,158	302,365
Long-Term Debt	5,703	7,412	12,022	13,759	14,102	13,425	16,411	36,074	26,884	22,254	21,914	26,581	22,071	27,009	22,254	21,914
Total Liabilities	305,692	333,984	452,544	493,917	523,383	477,944	506,193	682,281	739,828	772,328	777,235	760,938	762,782	782,236	772,328	777,235

Common Stock	8.00	8.00	8.00	8.00	8.00	8.00	8.00	10.00	11.00	11.00	11.00	11.00	11.00	11.00	11.00	11.00
Preferred Stock	--	--	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Retained Earnings	4,193	6,608	10,865	16,574	19,884	22,403	19,501	21,363	27,289	25,205	25,958	24,640	26,904	25,920	25,205	25,958
Additional Paid-In Capital	14,991	15,037	17,274	17,454	17,098	15,811	16,859	26,423	26,782	28,011	28,072	26,920	26,927	26,964	28,011	28,072
Treasury Stock	-835	-1,785	-959	-1,357	-2,890	-236	-190	-172	-172	-172	-172	-172	-172	-172	-172	-172
Total Equity	21,149	22,824	29,101	33,798	35,179	23,734	33,121	48,625	59,797	64,453	64,450	58,666	62,406	64,049	64,453	64,450
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	2,217	2,758	4,714	6,293	4,317	3,209	-2,278	2,786	6,971	1,362	1,362	--	--	--	1,362	--
Depreciation, Depletion and Amortization	478	441	352	394	--	375	520	585	679	596	596	--	--	--	596	--
Cash Flow from Others	4,668	4,867	2,939	-87.00	-3,130	7,119	5,561	4,625	2,640	15,202	12,177	5,758	6,344	3,186	-86.00	2,733
Cash Flow from Operations	7,363	8,066	8,005	6,600	1,187	10,703	3,803	7,996	10,290	17,160	14,135	5,758	6,344	3,186	1,872	2,733

Investment for Property, Plant & Equipement	--	--	--	--	--	--	-579	--	--	--	--	--	--	--	--	--
Cash Flow from Acquisitions	-13.00	22.00	-9,900	48.00	526	-786	118	-3,021	232	560	489	188	-188	--	560	117
Cash Flow from Investing	-17,688	-13,015	-22,610	-18,886	742	-2,671	-13,935	-18,314	-22,235	-11,929	-23,815	2,167	-14,944	-1,298	2,146	-9,719

Net Issuance of Stock	909	-949	72.00	-417	-1,705	2,011	1,035	3,576	2,950	1,000	1,000	--	--	--	1,000	--
Net Issuance of Preferred Stock	--	--	2,100	--	--	--	--	--	-2,805	--	--	--	--	--	--	--
Net Issuance of Debt	2,652	-472	2,454	437	-306	-10,908	-6,104	6,499	6,065	-1,916	-2.00	-2,154	6,740	-1,144	-5,358	-240
Cash Flow for Dividends	-175	-343	-457	-584	-678	-717	-732	-906	-909	-933	-1,136	-30.00	-31.00	-30.00	-842	-233
Other Financing	8,349	7,086	10,348	15,939	-179	15,802	1,698	4,212	4,081	1,884	1,257	2,424	-658	135	-17.00	1,797
Cash Flow from Financing	11,735	5,322	14,517	15,375	-2,868	6,188	-4,103	13,381	9,382	35.00	1,119	240	6,051	-1,039	-5,217	1,324

Net Change in Cash	1,410	373	-88.00	3,089	-939	13,871	-14,127	2,934	-2,585	5,277	-8,684	8,206	-2,632	915	-1,212	-5,755

Free Cash Flow	7,363	8,066	8,005	6,600	1,187	10,703	3,224	7,996	10,290	17,160	14,135	5,758	6,344	3,186	1,872	2,733
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score

Switch to Another Stock:

MET Quarterly/Annuals Reports

MET: 10-Q - METLIFE INC (0001099219) (Filer): (10-Q) - 2012-11-07
MET: 10-Q - METLIFE INC (0001099219) (Filer): (10-Q) - 2012-08-07
MET: 10-Q - METLIFE INC (0001099219) (Filer): (10-Q) - 2012-05-08
MET: 10-K - METLIFE INC (0001099219) (Filer): (10-K) - 2012-02-28
MET: 10-Q - METLIFE INC (0001099219) (Filer): (10-Q) - 2011-11-04

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

MET Quarterly/Annuals Reports